Network News
Global CDMO recognized for exceptional quality systems and regulatory track record; named finalist in Excellence in Client Service & Partnership and Manufacturing Operations categories SEATTLE – April 27, 2026 – AGC Biologics, your friendly CDMO expert, is the 2026 recipient of the Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance. The award recognizes the […]
read more
New “WHO Collaborating Centre for Novel Diagnostics for Infectious Diseases” at Heidelberg University Hospital
The Department of Infectious and Tropical Medicine at the Center for Infectious Diseases at Heidelberg University Hospital has been designated by the World Health Organization (WHO) as a “WHO Collaborating Center for Novel Diagnostics for Infectious Diseases.” As part of this collaboration, the department supports the WHO in achieving one of its fundamental goals: the […]
read more
SPT Labtech and EMBL GeneCore Collaborate to Advance Fully Walkaway Automation in Genomics Workflows
Cambridge, UK, and Heidelberg, Germany, 13 April 2026: SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and the European Molecular Biology Laboratory’s Genomics Core Facility (EMBL GeneCore), today announced a collaboration to advance fully walkaway automated genomics workflows. As part of the collaboration, SPT Labtech’s firefly®+ […]
read more
AskBio’s Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
Ametefgene parvec (AB-1005) manufactured at Viralgen commercial manufacturing facility with next-generation process to deliver high-purity product with greater efficiency Berlin, Germany, and Durham, N.C., USA, April 20, 2026 – AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that it has introduced its proprietary, commercially ready […]
read more
BioMed X and Servier Launch First Research Team in France to Pioneer AI-Driven Antibody Engineering
BioMed X, a leading innovation hub for pharma, has officially launched its first research team at BioMed X France, marking the establishment of its presence in one of Europe’s fastest-growing life science ecosystems. The new team, Team ADB (AI-Empowered Design of Bispecific Antibodies), is based within the XSeed Labs incubator on the R&D campus of Servier in […]
read more
Innovation Award of the German BioRegions 2026: Projects from Braunschweig, Frankfurt and Würzburg honored
On the occasion of German Biotech Days (DBT) 2026 in Leipzig, the Working Group of the German BioRegions once again presented its renowned Innovation Award on 21 April 2026. For the past 19 years, the award has honored innovative biotechnological ideas that have been patented or filed for patent protection and show strong potential for […]
read more
Paul Martini Prize for Professor Alwin Krämer
On April 20, 2026, Prof. Alwin Krämer, MD, of the Heidelberg Medical Faculty at Heidelberg University, who works at the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, received the 2026 Paul Martini Prize. The prize was awarded for groundbreaking improvements in treatment for some patients with metastases from an unknown primary tumor, known […]
read more
Fraunhofer IPA wins the “euRobotics Technology Transfer Award” together with Trumpf and Lorch
Technology transfer that works: At the “European Robotics Forum” (ERF) in late March, the trio of applicants won the prestigious award. The award recognizes research that has found its way into industrial applications. The application focused on a “no-code” solution that allows companies to deploy cobots without specialized knowledge or significant welding effort, even for […]
read more
Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria Paris and Tarrytown, NY, April 13, 2026. The European Commission has approved Dupixent (dupilumab) for the treatment of moderate-to-severe chronic spontaneous urticaria (CSU) in children aged two to 11 years with inadequate response to histamine-1 […]
read more
